
Releases
Rznomics Reports Initial Clinical Progress for Glioblastoma Therapy
Ten patients with recurrent glioblastoma have shown prolonged disease control after receiving RZ-001, a novel RNA-based gene therapy. Dr. Chae-Yong Kim of Seoul National University Bundang Hospital shared these interim results on June 13 at the Asian Society for Neuro-Oncology Annual Meeting in Kanazawa, Japan.
























